Canada

Fusion Pharmaceuticals is a clinical-stage oncology company that develops radiopharmaceuticals as precision medicines using its Targeted Alpha Therapies platform and Fast-Clear linker technology. Its lead product candidate, FPI-1434, is in Phase 1 clinical trials as a monotherapy for solid tumors expressing insulin-like growth factor 1 receptor. The company is also conducting preclinical studies of FPI-1434 in combination with approved checkpoint inhibitors and DNA damage response inhibitors. Fusion Pharmaceuticals has a strategic collaboration agreement with AstraZeneca UK Limited to jointly discover, develop, and commercialize alpha-emitting radiopharmaceuticals and combination therapies for cancer treatment.

Fusion Pharmaceuticals

Radiopharmaceutical oncology company with precision medicines

Google

Gerente de Produto

Cientista de Dados

Fusion Pharmaceuticals

Fusion Pharmaceuticals Vagas Abertas

Está pronto para acelerar sua carreira? Confira essas vagas abertas na Fusion Pharmaceuticals.